Market Leaders - IPV Vaccines Industry

The IPV are very safe. The injection may give a bit of redness or pain. To prevent from Poliomyelitis, which affects children under the age of 5. This infection can turn into irreversible paralysis and can cause death. There are two types of vaccines used: an inactivated poliovirus (IPV) and a weakened poliovirus given by injection (OPV). 90% or more of individuals develop protective vaccine, after two doses of inactivated polio vaccine. In 1990’s IPV replaced the oral vaccines due to the risk of vaccine-derived polio in oral vaccines in many countries.

As of 2021 The IPV Vaccines Market is estimated to be valued at US$ 160 Million and is expected to exhibit a CAGR of 8.5% and US$ 240 Million by the year 2028.

Key Leaders in the IPV Vaccines Industry:

1) Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc.

In December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.

2) GlaxoSmithKline GSK plc.       

GSK Plc. Is a British Multinational pharmaceutical and biotechnology company founded in the year 2000. The headquarters are located in London, England, UK. GlaxoSmithKline is the tenth largest pharmaceutical company and has ranked 294^th on the 2002 Fortune Globes 500. The company was founded by Joseph Nathan. The company manufacture products for major diseases like asthma, cancer, infections and mental health.

In April 2022, the company announced its plans of acquiring Sierra Oncology Inc. for U.S$1.9 Billion. In May 2022, GSK announced it would acquire Affinivax and its phase II 24- Valent pneumococcal vaccine candidate for up to $3.3 Billion.

3) Serum Institute of India

Serum Institute of India is the world’s largest vaccine manufacturer and has produced and sold around 1.5 billion vaccines globally. The serum Institute of India was founded in 1966. Dr Cyrus Poonawalla incorporated this institution. The headquarters are located in Pune, Maharashtra. Over The years the company has produced many vaccines and its products have been used in various programmes ran by UNICEF, the World Health Organization.

In 2023 Serum Institute of India launched the first made in India qHPV vaccine “CERVAVAC”

4) PT Bio Farma

PT Bio Farm (Persero) is a Pharmaceuticals company based in Bandung, Indonesia and also the only local vaccine manufacturer located in Indonesia. The company produces vaccines and sera to help support immunization in Indonesia as well as in other countries. Bio Farma has manufactured vaccines to fight measles, polio, hepatitis B. The company was founded in 1890 and the headquarters are located in Bandung, Indonesia.

In 2022 the Minister of Health of Indonesia launched Molecular Diagnostic Kit for Colorectal Cancer that was made by Bio Farma. In November 2002 Bio Farma won IDC Future Enterprise Awards 2022 Indonesia.

5) AJ Vaccines

AJ Vaccines is a global pharmaceutical company that is known for developing and manufacturing vaccines against serious diseases like tuberculosis, Tetanus, Diphtheria and Polio. The company was founded in the year 2017 and the headquarters are located in Copenhagen, Denmark.